ArticleFrontiers in oncology2018

Biglycan Regulates MG63 Osteosarcoma Cell Growth Through a LPR6/β-Catenin/IGFR-IR Signaling Axis.

John Aggelidakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.